Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Elastic modulus affects the growth and differentiation of neural stem cells.
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes.
[Anesthetic management of a Dialysis Patient with Chronic Inflammatory Demyelinating Polyneuropathy].
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
Learning and cognitive fatigue trajectories in multiple sclerosis defined using a burst measurement design.
Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication.
Sleep-disordered breathing in multiple sclerosis.
Risk factors for falls in multiple sclerosis: an observational study.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Learning a cost function for microscope image segmentation.
Regulation of the vitamin D receptor gene by environment, genetics and epigenetics.
[Stem cell transplantation for multiple sclerosis : Hamburg experiences and state of international research].
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Trial and error in clinical studies: lessons from ATAMS.
Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Autoantigens and autoantibodies in multiple sclerosis.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Goodbye to all that: a short history of CCSVI.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].

Pages